TY - JOUR
T1 - Basic science review
T2 - Pathophysiology of otosclerosis
AU - Chole, Richard A.
AU - McKenna, Michael
PY - 2001
Y1 - 2001
N2 - Objective: To review current knowledge of the pathophysiology of otosclerosis and to review hypotheses for the amelioration of this disease. Data Sources: Review of the literature and experimental observations by the authors. Conclusions: Otosclerosis is a localized disease of bone remodeling within the otic capsule of the human temporal bone. Unlike other similar bone diseases, it does not occur outside of the temporal bone. These lesions seem to begin by resorption of stable otic capsule bone in adults, followed by a reparative phase with bone deposition. There are clearly genetic factors that lead to this disease, but measles virus infection and autoimmunity also may play contributing roles. Surgical correction of the conductive hearing loss is highly effective, but nonsurgical intervention has not yet been shown to prevent or slow the disease. Of the factors that may inhibit this process, fluorides, cytokine inhibitors, and bisphosphonates, third-generation bisphosphonates appear to hold the most promise.
AB - Objective: To review current knowledge of the pathophysiology of otosclerosis and to review hypotheses for the amelioration of this disease. Data Sources: Review of the literature and experimental observations by the authors. Conclusions: Otosclerosis is a localized disease of bone remodeling within the otic capsule of the human temporal bone. Unlike other similar bone diseases, it does not occur outside of the temporal bone. These lesions seem to begin by resorption of stable otic capsule bone in adults, followed by a reparative phase with bone deposition. There are clearly genetic factors that lead to this disease, but measles virus infection and autoimmunity also may play contributing roles. Surgical correction of the conductive hearing loss is highly effective, but nonsurgical intervention has not yet been shown to prevent or slow the disease. Of the factors that may inhibit this process, fluorides, cytokine inhibitors, and bisphosphonates, third-generation bisphosphonates appear to hold the most promise.
KW - Genetics
KW - Hearing loss
KW - Otosclerosis
UR - http://www.scopus.com/inward/record.url?scp=0035077805&partnerID=8YFLogxK
U2 - 10.1097/00129492-200103000-00023
DO - 10.1097/00129492-200103000-00023
M3 - Review article
C2 - 11300278
AN - SCOPUS:0035077805
SN - 1531-7129
VL - 22
SP - 249
EP - 257
JO - Otology and Neurotology
JF - Otology and Neurotology
IS - 2
ER -